- 4 hrs ago Daily Horoscope, 24 May 2022: Check Today's Horoscope Predictions For All Zodiac Signs
- 19 hrs ago What Are Empty Calories? Major Sources, Disadvantages And How To Replace Them
- 20 hrs ago Omicron Subvariants BA.4 And BA.5 In India: What You Need To Know
- 21 hrs ago First Death Of A Child Reported In Mexico Due To Mysterious Severe Hepatitis: Things To Know
- Movies Bhool Bhulaiyaa 2 Day 4 Box Office Collection: Kartik Aaryan's Film Holds Strong
- News DD’s FreeDish gets more diverse with Masterchef Sanjeev Kapoor dedicating recipes
- Technology Apple iPhone 13 Pro Max Price Drop Alert: Available With Rs. 21,000 Discount And A Catch
- Finance Adani Power Stock Hits An All-Time High With A Massive Return
- Sports French Open: Djokovic starts title defence with emphatic defeat of Nishioka
- Travel GlampEco - Glamping At India's First Geodesic Dome Stay
- Education NABARD AM Prelims Mains 2021 Cut Off Marks, Check NABARD Assistant Manager RDBS Rajbhasha Cut Off Details Here
- Automobiles KTM RC 390 Launched At Rs 3.14 Lakhs
Genetically predetermined limits on the immune system may be the key to why COVID-19 has such a devastating effect on the elderly, according to a modelling study.
Researchers at the University of Washington (UW) in the US noted that the immune system's ability to combat COVID-19, like any infection, largely depends on the replication of the immune cells effective at destroying the SARS-CoV-2 virus that causes the disease.
The study, published recently in The Lancet eBioMedicine journal, suggests that the body's ability to produce these cloned immune cells, which cannot be infinitely created, falls off significantly in old age.
"When DNA split in cell division, the end cap -- called a telomere -- gets a little shorter with each division," said professor James Anderson, a modeller of biological systems at UW.
"After a series of replications of a cell, it gets too short and stops further division. Not all cells or all animals have this limit, but immune cells in humans have this cell life," Anderson said in a statement.
The average person's immune system coasts along pretty good despite this limit until about 50 years old, the researchers said.
That is when enough core immune cells, called T cells, have shortened telomeres and cannot quickly clone themselves through cellular division in big enough numbers to attack and clear the COVID-19 virus, which has the trait of sharply reducing immune cell numbers, they said.
According to Anderson, telomere lengths are inherited from parents.
There are some differences in these lengths between people at every age as well as how old a person becomes before these lengths are mostly used up.
"Depending on your parents and very little on how you live, your longevity or, as our paper claims, your response to COVID-19 is a function of who you were when you were born," he said.
To build their model, the researchers used publicly available data on COVID-19 mortality from the Center for Disease Control and US Census Bureau and studies on telomeres, many of which were published by the co-authors over the past two decades.
Assembling telomere length information about a person or specific demographic could help doctors know who was less susceptible, the researchers said.
The doctors could allocate resources, such as booster shots, according to which populations and individuals may be more susceptible to COVID-19, they added.
- wellnessFirst Death Of A Child Reported In Mexico Due To Mysterious Severe Hepatitis: Things To Know
- wellnessDr Reddy's Lab To Approach Regulator For Sputnik Light As Universal Booster Dose
- wellnessHaven't Had Covid-19 Yet? It Could Be More Than Just Luck
- wellnessSome Short-Term Benefits Of Additional Booster Dose Of mRNA Vaccine In Health Workers: WHO
- wellnessWhy People With Lung Disorder Face Risk Of Severe Covid-19 Found
- wellnessOestrogen Treatment Linked With Reduced Covid Mortality: Study
- wellnessTrained Sniffer Dogs May Accurately Detect COVID Infected Airport Passengers: Study
- wellnessBiological E Ltd Reduces Price Of Its Covid-19 Vaccine Corbevax To Rs 250 Per Dose
- wellnessSouth Africa In New Surge Of COVID-19 From Versions Of Omicron
- wellnessCovid-19 Virus Is Not Viable On Cash Banknotes, Study Finds
- wellnessNew Computer Model Can Help Assess Covid-19 Impact, Progression In Detail
- wellnessActive Covid-19 Cases In The Country Dip To 18,604